IMPACT ON ITALIAN NATIONAL HEALTH SERVICE EXPENDITURE FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM WITH RIVAROXABAN

被引：0
|
作者：
Roggeri, A. [1 ]
Roggeri, D. P. [1 ]
Pengo, V [2 ]
机构：
[1] ProCure Solut, Nembro, BG, Italy
[2] Univ Hosp Padova, Padua, Italy
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.829
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV60
引用
收藏
页码：A384 / A384
页数：1
相关论文
共 50 条
  • [21] Healthcare costs associated with rivaroxaban or warfarin use for the treatment of venous thromboembolism
    Coleman, Craig I.
    Baugh, Christopher
    Crivera, Concetta
    Milentijevic, Dejan
    Wang, Sheng-Wei
    Lu, Lang
    Nelson, Winnie W.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (02) : 200 - 203
  • [22] Safety and effectiveness of oral rivaroxaban for the treatment of venous thromboembolism in cancer patients
    Kondo, Y.
    Hirabatake, M.
    Satake, H.
    Yasui, H.
    Hashida, T.
    ANNALS OF ONCOLOGY, 2017, 28 : 165 - 165
  • [23] APIXABAN AND RIVAROXABAN VERSUS WARFARIN FOR TREATMENT OF VENOUS THROMBOEMBOLISM IN OBESE PATIENTS
    Kafka, Wesley
    Cook, Stephen
    Ferris, Jessica
    Hill, Sharon
    CRITICAL CARE MEDICINE, 2020, 48
  • [24] Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism
    Kovacs, Matthew R.
    Lazo-Langner, Alejandro
    Louzada, Martha L.
    Kovacs, Michael J.
    THROMBOSIS RESEARCH, 2020, 195 : 231 - 232
  • [25] Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location
    Janczak, Dawid T.
    Mimier, Malgorzata K.
    McBane, Robert D.
    Kamath, Patrick S.
    Simmons, Benjamin S.
    Bott-Kitslaar, Dalene M.
    Lenz, Charles J.
    Vargas, Emily R.
    Hodge, David O.
    Wysokinski, Waldemar E.
    MAYO CLINIC PROCEEDINGS, 2018, 93 (01) : 40 - 47
  • [26] Treatment with rivaroxaban and monitoring of coagulation profiles in two dogs with venous thromboembolism
    Uchida, Mona
    Ohmi, Aki
    Fujiwara, Reina
    Fukushima, Kenjiro
    Doi, Akihiro
    Azuma, Kazushi
    Tsujimoto, Hajime
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2020, 82 (09): : 1271 - 1276
  • [27] Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban
    Friedman, Richard J.
    Sengupta, Nishan
    Lees, Michael
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (03) : 299 - 306
  • [28] Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism
    Krause, Manuela
    Henningsen, Anna
    Torge, Antje
    Juhl, David
    Junker, Ralf
    Kenet, Gili
    Kowalski, Dorothee
    Limperger, Verena
    Mesters, Rolf
    Anonymous
    Rocke, Angela
    Shneyder, Maria
    Clausnizer, Hartmut
    Schiesewitz, Hanna
    Nowak-Goettl, Ulrike
    THROMBOSIS RESEARCH, 2016, 148 : 145 - 151
  • [29] Health Economic Analysis of Rivaroxaban and Warfarin for Venous Thromboembolism Management in Chinese Patients
    Fung, Ka-Po
    Chan, Kei-Hong
    Ng, Vivien
    Tsui, Ping-Tim
    You, Joyce H. S.
    CARDIOVASCULAR DRUGS AND THERAPY, 2019, 33 (03) : 331 - 337
  • [30] Health Economic Analysis of Rivaroxaban and Warfarin for Venous Thromboembolism Management in Chinese Patients
    Ka-Po Fung
    Kei-Hong Chan
    Vivien Ng
    Ping-Tim Tsui
    Joyce H. S. You
    Cardiovascular Drugs and Therapy, 2019, 33 : 331 - 337
12345